Ciprofloxacin or Imipenem Use Correlates with Resistance in Pseudomonas aeruginosa

Ciprofloxacin or Imipenem Use Correlates with Resistance in Pseudomonas aeruginosa

OBJECTIVE: To investigate the relationship between ciprofloxacin or imipenem use and antimicrobial resistance in Pseudomonas aeruginosa.

Saved in:

Bibliographic Details
Main Authors:	George G Zhanel, Lindsay E Nicolle, Alfred S Gin, James Karlowsky, Amin Kabani, Daryl J Hoban
Format:	Article
Language:	English
Published:	Wiley 1998-01-01
Series:	Canadian Journal of Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/1998/210742
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mutant Prevention Concentrations of Doripenem and Meropenem Alone and in Combination with Colistin (Polymyxin E), Levofloxacin and Tobramycin in Pseudomonas aeruginosa
by: George G Zhanel, et al.
Published: (2009-01-01)

Phenotypic Detection of Metallo-β-Lactamase in Imipenem-Resistant Pseudomonas aeruginosa
by: Yalda Khosravi, et al.
Published: (2012-01-01)

Characterization of Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals: Results of the CANWARD 2007 Study
by: Andrew Walkty, et al.
Published: (2009-01-01)

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
by: E. Dahdouh, et al.
Published: (2014-01-01)

Low Prevalence of VRE Gastrointestinal Colonization of Hospitalized Patients in Manitoba Tertiary Care and Community Hospitals
by: George G Zhanel, et al.
Published: (2000-01-01)

Low Prevalence of Gastrointestinal Colonization with Antimicrobial-Resistant Bacteria in High Risk Units in a Canadian Tertiary Care Centre
by: John M Embil, et al.
Published: (1996-01-01)

Real-World Experience of Imipenem–Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study)
by: Isabel Machuca, et al.
Published: (2024-11-01)

Overview of Mink Immunity and Resistance to Pseudomonas aeruginosa
by: Jiangsong Bai, et al.
Published: (2023-01-01)

In Vitro Activities of Ceftobiprole and Doripenem Tested against Frequently Encountered Aerobic and Facultative Gram-Positive and Gram-Negative Bacterial Pathogens Isolated from Patients in Canadian Hospitals in 2007
by: James A Karlowsky, et al.
Published: (2009-01-01)

Utilization of Colistin for Treatment of Multidrug-Resistant Pseudomonas aeruginosa
by: Deana M Sabuda, et al.
Published: (2008-01-01)

Multidrug resistance of Pseudomonas aeruginosa: do virulence properties impact on resistance patterns?
by: Poulomi Saha, et al.
Published: (2025-02-01)

Investigation of virulence factors in resistance and sensitive pseudomonas aeruginosa clinical isolates
by: Zeinab Waheed kadim, et al.
Published: (2025-01-01)

Correlation Analysis Between Multi-Drug Resistance Phenotype and Virulence Factor Expression of Clinical <i>Pseudomonas aeruginosa</i>
by: Wenli Xu, et al.
Published: (2025-01-01)

Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in Pseudomonas aeruginosa in Argentina
by: Silvia Boni, et al.
Published: (2022-01-01)

Anti-Biofilm Agents to Overcome <i>Pseudomonas aeruginosa</i> Antibiotic Resistance
by: Marie Hanot, et al.
Published: (2025-01-01)

Evaluation of Risk Factors for Antibiotic Resistance in Patients with Nosocomial Infections Caused by Pseudomonas aeruginosa
by: Meliha Cagla Sonmezer, et al.
Published: (2016-01-01)

Confirmatory identification and antibiotics resistance profiling of Pseudomonas aeruginosa: a laboratory-based study
by: Hafsa Abdulhamid Abdulsalam
Published: (2025-01-01)

In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa
by: Vladimir Chachanidze, et al.
Published: (2009-01-01)

Spontaneous Nosocomial Pseudomonas aeruginosa Meningitis Presenting as Trismus
by: C. J. Parr, et al.
Published: (2017-01-01)

Clinical Predictors of Pseudomonas aeruginosa Bacteremia in Emergency Department
by: Yongsoon Choi, et al.
Published: (2018-01-01)

Antimicrobial resistance, virulence gene profiling, and genetic diversity of multidrug-resistant Pseudomonas aeruginosa isolates in Mazandaran, Iran
by: Ghazaleh Elahi, et al.
Published: (2024-12-01)

Non-carbapenem-producing carbapenem-resistant Pseudomonas aeruginosa in children: Risk factors, molecular epidemiology, and resistance mechanism
by: Lijun Yin, et al.
Published: (2025-02-01)

Genetic Diversity of Imipenem-Resistant Acinetobacter baumannii Infections at an Intensive Care Unit
by: Amani Alnimr, et al.
Published: (2020-01-01)

Correction: Antimicrobial resistance, virulence gene profiling, and genetic diversity of multidrug-resistant Pseudomonas aeruginosa isolates in Mazandaran, Iran
by: Ghazaleh Elahi, et al.
Published: (2025-02-01)

Pseudomonas aeruginosa alkyl quinolone response is dampened by Enterococcus faecalis
by: Maggie M. Fink, et al.
Published: (2025-02-01)

Pyoverdine, the Major Siderophore in Pseudomonas aeruginosa, Evades NGAL Recognition
by: Mary E. Peek, et al.
Published: (2012-01-01)

Does Pseudomonas aeruginosa Colonization Affect Exercise Capacity in CF?
by: Asterios Kampouras, et al.
Published: (2019-01-01)

Antimicrobial photodynamic inactivation of Pseudomonas aeruginosa persister cells and biofilms
by: Mona Mahmoud, et al.
Published: (2025-02-01)

PEG-PLGA nanoparticles deposited in Pseudomonas aeruginosa and Burkholderia cenocepacia
by: Tinatini Tchatchiashvili, et al.
Published: (2024-12-01)

Persistent Bacteremia from Pseudomonas aeruginosa with In Vitro Resistance to the Novel Antibiotics Ceftolozane-Tazobactam and Ceftazidime-Avibactam
by: Louie Mar Gangcuangco, et al.
Published: (2016-01-01)

Essential oils modulate virulence phenotypes in a multidrug-resistant pyomelanogenic Pseudomonas aeruginosa clinical isolate
by: Jayalekshmi Haripriyan, et al.
Published: (2025-01-01)

Osteomyelitis Due to Multiple Carbapenemase-Producing Gram-Negative Bacteria: The First Case Report of a GES-13-Producing Pseudomonas aeruginosa Isolate in Canada
by: Shadi Sepehri, et al.
Published: (2014-01-01)

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways
by: Erik Skoglund, et al.
Published: (2018-01-01)

Sources and Transmission Routes of Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>: Study Design and Methodology of the SAMPAN Study
by: Anneloes van Veen, et al.
Published: (2025-01-01)

Conjugation of LasR Quorum-Sensing Inhibitors with Ciprofloxacin Decreases the Antibiotic Tolerance of P. aeruginosa Clinical Strains
by: Daria Bortolotti, et al.
Published: (2019-01-01)

Chronic wounds and adaptive Pseudomonas aeruginosa: A phenotypic and genotypic characterization
by: Kasandra Buchholtz, et al.
Published: (2025-01-01)

Refined methodology for quantifying Pseudomonas aeruginosa virulence using Galleria mellonella
by: Christopher M. R. Axline, et al.
Published: (2025-02-01)

Pseudomonas Aeruginosa and Cystic Fibrosis: Antibiotic Therapy and the Science behind the Magic
by: Noni E MacDonald
Published: (1997-01-01)

Effects of аntimicrobials on <i>Pseudomonas aeruginosa</i> biofilm formation
by: U. M. Nemchenko, et al.
Published: (2022-09-01)

Decoding MexB efflux pump genes: structural, molecular, and phylogenetic analysis of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa
by: Muhammad Bilal Habib, et al.
Published: (2025-01-01)